CHAM
TEVA icon

Clear Harbor Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Clear Harbor Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
38,972
-49,150
-56% -$1.64M 0.08% 177
2026
Q1 		$2.65M Sell
88,122
-3,225
-4% -$104K 0.18% 106
2025
Q4 		$2.85M Sell
91,347
-2,938
-3% -$72.4K 0.19% 104
2025
Q3 		$1.9M Buy
94,285
+135
+0.1% +$2.37K 0.13% 131
2025
Q2 		$1.58M Buy
94,150
+1,825
+2% +$29.4K 0.12% 134
2025
Q1 		$1.42M Sell
92,325
-17,250
-16% -$308K 0.11% 134
2024
Q4 		$2.42M Sell
109,575
-6,500
-6% -$118K 0.19% 97
2024
Q3 		$2.09M Buy
116,075
+250
+0.2% +$4.38K 0.17% 103
2024
Q2 		$1.88M Sell
115,825
-5,000
-4% -$77K 0.16% 106
2024
Q1 		$1.7M Sell
120,825
-9,500
-7% -$120K 0.15% 118
2023
Q4 		$1.36M Buy
130,325
+63,225
+94% +$590K 0.12% 129
2023
Q3 		$684K Buy
67,100
+5,000
+8% +$46.6K 0.07% 178
2023
Q2 		$468K Buy
62,100
+55,100
+787% +$447K 0.05% 224
2023
Q1 		$62K Buy
+7,000
New +$69.2K 0.01% 373
2022
Q3 		– Sell
-298,680
Closed -$2.25M – 395
2022
Q2 		$2.25M Buy
298,680
+134,910
+82% +$1.18M 0.3% 66
2022
Q1 		$1.54M Buy
+163,770
New +$1.37M 0.17% 108
2020
Q1 		– Sell
-100
Closed -$980 – 631
2019
Q4 		$980 Buy
+100
New +$893 ﹤0.01% 762

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Clear Harbor Asset Management's TEVA Position: Q2 2026 in Review

Clear Harbor Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 56% in Q2 2026, selling an estimated $1.64M and leaving 38,972 shares worth $1.32M. The position accounts for 0.08% of the portfolio, ranked #177.

Clear Harbor Asset Management first reported a position in TEVA in Q4 2019 and has held it in 17 quarters since. The position peaked at $2.85M in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Clear Harbor Asset Management held 38,972 shares of Teva Pharmaceuticals worth $1.32M as of Q2 2026.
  • Clear Harbor Asset Management sold 49,150 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.64M.
  • Teva Pharmaceuticals made up 0.08% of Clear Harbor Asset Management's portfolio in Q2 2026, its #177 holding.
  • Clear Harbor Asset Management first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 17 quarters since.
  • Clear Harbor Asset Management's Teva Pharmaceuticals position peaked at $2.85M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.